NCT01788540

Intralipid for Recurrent Miscarriage

The Role of Intralipid in Natural Killer Cell Positive Cases With Recurrent Miscarriages Undergoing IVF/ICSI Cycles: a Double Blind Randomized Controlled Trial

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 300 (estimated)
• Sponsor: Woman's Health University Hospital, Egypt · Academic / Other
• Sex: Female
• Age: 18 Years – 40 Years
• Healthy volunteers: Accepted

Summary

Intralipid infusion can improve the outcome in NK cells positive females with history of recurrent miscarriages undergoing IVF/ICSI cycles.

Conditions

• Abortion, Spontaneous
• Abortion, Habitual

Interventions

Type	Name	Description
DRUG	Intralipid	IV infusion of intralipid 20% is administrated on the day of vaginal egg collection in a dose of 9 mg/ml total blood volume corresponding to intralipid 2 ml 20% diluted in 250 ml saline over 30-60 minutes.the intralipid infusion is then repeated within the 1st week of positive pregnancy test and every 2 weeks till end of first trimester

Timeline

• Start date: 2013-02-01
• Primary completion: 2016-08-01
• Completion: 2016-09-01
• First posted: 2013-02-11
• Last updated: 2018-01-26

Locations

1 site across 1 country: Egypt